Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma (Q37214249)
Jump to navigation
Jump to search
scientific article published on May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma |
scientific article published on May 2009 |
Statements
1 reference
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma (English)
1 reference
Henry S Friedman
1 reference
Sridharan Gururangan
1 reference
Annick Desjardins
1 reference
David A Reardon
1 reference
James J Vredenburgh
1 reference
Merrill J Egorin
1 reference
James E Herndon
1 reference
Theodore F Lagattuta
1 reference
August J Salvado
1 reference
Jan H Beumer
1 reference
1 reference
1 reference
Identifiers
1 reference